Ning‐I Yang
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Genetics top 10%
- Mesenchymal stem cell research
Papers in
-
- Heart Failure Treatment and Management 12
- Cardiovascular Function and Risk Factors 7
-
- Diabetes Treatment and Management 8
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
- Co-authors
- Chao‐Hung Wang (17 shared papers)Wen‐Jin Cherng (24 shared papers)Ming‐Jui Hung (27 shared papers)Chi‐Wen Cheng (14 shared papers)Min‐Hui Liu (7 shared papers)Li‐Tang Kuo (11 shared papers)Yu-Yen Huang (4 shared papers)Chun‐Tai Mao (5 shared papers)
In The Last Decade
Ning‐I Yang
54 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 76
- Cardiology and Cardiovascular Medicine 554
- Genetics 113
- Complementary and alternative medicine 97
- Nephrology 73
- Endocrinology, Diabetes and Metabolism 125
Countries citing papers authored by Ning‐I Yang
This map shows the geographic impact of Ning‐I Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning‐I Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning‐I Yang more than expected).
Fields of papers citing papers by Ning‐I Yang
This network shows the impact of papers produced by Ning‐I Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning‐I Yang. The network helps show where Ning‐I Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning‐I Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 268 | |
| 2 | 2006 | 110 | |
| 3 | 2007 | 102 | |
| 4 | 2015 | 92 | |
| 5 | 2006 | 89 | |
| 6 | 2017 | 73 | |
| 7 | 2006 | 67 | |
| 8 | 2005 | 58 | |
| 9 | 2018 | 40 | |
| 10 | 2012 | 38 | |
| 11 | 2007 | 36 | |
| 12 | 2016 | 36 | |
| 13 | 2014 | 34 | |
| 14 | 2023 | 32 | |
| 15 | 2004 | 28 | |
| 16 | 2012 | 26 | |
| 17 | 2022 | 26 | |
| 18 | 2008 | 24 | |
| 19 | 2004 | 20 | |
| 20 | 2008 | 20 |
About Ning‐I Yang
Ning‐I Yang is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging, Nephrology and Physiology, having authored 59 papers that have together received 1.4k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (12 papers), Diabetes Treatment and Management (8 papers), Cardiac Imaging and Diagnostics (7 papers), Cardiovascular Function and Risk Factors (7 papers), Coronary Interventions and Diagnostics (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (554 citations), Genetics (113 citations), Complementary and alternative medicine (97 citations), Nephrology (73 citations) and Endocrinology, Diabetes and Metabolism (125 citations). Ning‐I Yang has collaborated with scholars based in Taiwan, Canada and Japan. Frequent co-authors include Chao‐Hung Wang, Wen‐Jin Cherng, Ming‐Jui Hung, Chi‐Wen Cheng, Min‐Hui Liu, Li‐Tang Kuo, Yu-Yen Huang, Chun‐Tai Mao, Subodh Verma and Cheng-Yu Huang. Their work appears in journals such as The American Journal of Cardiology, The American Journal of the Medical Sciences, Scientific Reports, Medicine and Journal of Thrombosis and Thrombolysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.